Clinical Trial: The Mechanisms of Stapokibart in Regulating Nasal Microecology for Patients with Type 2 Chronic Rhinosinusitis With Nasal Polyps Based on Microbiomics and Metabolomics (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Mechanisms of Stapokibart in Regulating Nasal Microecology for Patients with Type 2 Chronic Rhinosinusitis With Nasal Polyps Based on Microbiomics and Metabolomics'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130999

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Soochow University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333562

Published by HT Digital Content Services with permission from Health Daily Digest....